racemetirosine has been researched along with Cardiovascular Diseases in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wachtel, H | 1 |
| Kennedy, EH | 1 |
| Zaheer, S | 1 |
| Bartlett, EK | 1 |
| Fishbein, L | 1 |
| Roses, RE | 1 |
| Fraker, DL | 1 |
| Cohen, DL | 1 |
1 other study available for racemetirosine and Cardiovascular Diseases
| Article | Year |
|---|---|
Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; alpha-Methyltyrosine; Cardiovascular Diseases; Enzyme Inhibi | 2015 |